Disrupting HOXD10 in this regulatory axis significantly mitigated the phenotypic effects of transendothelial migration and metastasis in BAP31-overexpressing CRC cells, providing further insights into the molecular mechanisms that drive the progression of BAP31-associated tumors. The gene discussed is HOXD10; the disease is colorectal carcinoma.